[{"Assets_0_Q3_USD":364785000.0,"CommonStockSharesOutstanding_0_Q3_shares":54125000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-176936000.0,"NetIncomeLoss_1_Q3_USD":-71895000.0,"NetIncomeLoss_3_Q3_USD":-212480000.0,"StockholdersEquity_0_Q3_USD":318442000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]